Emma Ritsmer Stormholt1, Jesper Svane2,3, Thomas Hadberg Lynge2, Jacob Tfelt-Hansen2,3. 1. The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Section 2142, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark. emma@stormholt.dk. 2. The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Section 2142, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark. 3. Section of Forensic Pathology, Department of Forensic Medicine, Copenhagen University, Copenhagen, Denmark.
Abstract
PURPOSE OF REVIEW: Sports-related sudden cardiac death (Sr-SCD) is a leading natural cause of death in young athletes. To prevent Sr-SCD in athletes, it is important to identify individuals at risk. This review sought to summarize the current knowledge of symptoms prior to Sr-SCD in athletes aged 1-49 years. RECENT FINDINGS: Cardiovascular screening of athletes is a subject of interest. However, the cost of ECG screening in a young population is relatively high compared to potential benefits, and systematic screening of athletes is heavily debated. In the background population, both cardiac and non-specific symptoms are often present prior to SCD. Both cardiac and non-specific symptoms are present in up to 74% prior to Sr-SCD. The main symptoms are syncope, chest pain, palpitations and dizziness. Knowledge of symptoms could potentially be used in combination with non-invasive prediction models to prevent Sr-SCD and treat athletes at risk.
PURPOSE OF REVIEW: Sports-related sudden cardiac death (Sr-SCD) is a leading natural cause of death in young athletes. To prevent Sr-SCD in athletes, it is important to identify individuals at risk. This review sought to summarize the current knowledge of symptoms prior to Sr-SCD in athletes aged 1-49 years. RECENT FINDINGS: Cardiovascular screening of athletes is a subject of interest. However, the cost of ECG screening in a young population is relatively high compared to potential benefits, and systematic screening of athletes is heavily debated. In the background population, both cardiac and non-specific symptoms are often present prior to SCD. Both cardiac and non-specific symptoms are present in up to 74% prior to Sr-SCD. The main symptoms are syncope, chest pain, palpitations and dizziness. Knowledge of symptoms could potentially be used in combination with non-invasive prediction models to prevent Sr-SCD and treat athletes at risk.
Authors: Anders Gaarsdal Holst; Bo Gregers Winkel; Juliane Theilade; Ingrid Bayer Kristensen; Jørgen Lange Thomsen; Gyda Lolk Ottesen; Jesper Hastrup Svendsen; Stig Haunsø; Eva Prescott; Jacob Tfelt-Hansen Journal: Heart Rhythm Date: 2010-05-15 Impact factor: 6.343
Authors: Thomas Hadberg Lynge; Alexander Gade Jeppesen; Bo Gregers Winkel; Charlotte Glinge; Michael Rahbek Schmidt; Lars Søndergaard; Bjarke Risgaard; Jacob Tfelt-Hansen Journal: Circ Arrhythm Electrophysiol Date: 2018-06
Authors: Bjarke Risgaard; Bo Gregers Winkel; Reza Jabbari; Charlotte Glinge; Ole Ingemann-Hansen; Jørgen Lange Thomsen; Gyda Lolk Ottesen; Stig Haunsø; Anders Gaarsdal Holst; Jacob Tfelt-Hansen Journal: Heart Rhythm Date: 2014-05-23 Impact factor: 6.343
Authors: Charlotte Glinge; Reza Jabbari; Bjarke Risgaard; Thomas Hadberg Lynge; Thomas Engstrøm; Christine M Albert; Stig Haunsø; Bo Gregers Winkel; Jacob Tfelt-Hansen Journal: J Cardiovasc Electrophysiol Date: 2015-05-12
Authors: Paolo Angelini; Benjamin Y Cheong; Veronica V Lenge De Rosen; Alberto Lopez; Carlo Uribe; Anthony H Masso; Syed W Ali; Barry R Davis; Raja Muthupillai; James T Willerson Journal: Tex Heart Inst J Date: 2018-08-01
Authors: Babken Asatryan; Cristina Vital; Christoph Kellerhals; Argelia Medeiros-Domingo; Christoph Gräni; Lukas D Trachsel; Christian M Schmied; Ardan M Saguner; Prisca Eser; David Herzig; Stephan Bolliger; Katarzyna Michaud; Matthias Wilhelm Journal: PLoS One Date: 2017-03-28 Impact factor: 3.240